Search Results - "Cai, Yi-Ran"

ctDNA-adjusted bTMB as a predictive biomarker for patients with NSCLC treated with PD-(L)1 inhibitors.

Authors: Nie, Wei Wang, Zhi-Jie Zhang, Kai et al.

Source: BMC Medicine. 5/5/2022, Vol. 20 Issue 1, p1-12. 12p.

Perfluoroalkyl Substances in Water from the Yangtze River and Its Tributaries at the Dividing Point Between the Middle and Lower Reaches.

Authors: Tan, Ke-Yan Lu, Guo-Hui Yuan, Xin et al.

Source: Bulletin of Environmental Contamination & Toxicology. Nov2018, Vol. 101 Issue 5, p598-603. 6p. 1 Chart, 1 Graph, 2 Maps.

Micropapillary: A component more likely to harbour heterogeneous EGFR mutations in lung adenocarcinomas.

Authors: Cai, Yi-Ran Dong, Yu-Jie Wu, Hong-Bo et al.

Source: Scientific Reports. 4/8/2016, p23755. 1p.

DNA methylation and immune evasion in triple-negative breast cancer: challenges and therapeutic opportunities.

Authors: Cai WY Cai XX Fei YR et al.

Source: Frontiers in oncology [Front Oncol] 2025 Feb 06; Vol. 15, pp. 1534055. Date of Electronic Publication: 2025 Feb 06 (Print Publication: 2025).

Publication Type: Journal Article; Review

Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE